ACM
BIIB icon

Ashford Capital Management’s Biogen BIIB Stock Holding History

Ashford Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-800
Closed -$227K – 110
2020
Q3 		$227K Sell
800
-200
-20% -$55.8K 0.03% 93
2020
Q2 		$268K Buy
+1,000
New +$301K 0.03% 89

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ashford Capital Management's BIIB Position: Q4 2020 in Review

Ashford Capital Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 800 shares — an estimated $227K sold.

Ashford Capital Management first reported a position in BIIB in Q2 2020 and held it in 2 quarters. The position peaked at $268K in Q2 2020. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Ashford Capital Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Ashford Capital Management sold 800 Biogen shares in Q4 2020, an estimated $227K.
  • Ashford Capital Management first reported a position in Biogen in Q2 2020 and held it in 2 quarters.
  • Ashford Capital Management's Biogen position peaked at $268K in Q2 2020.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Ashford Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.